Takeda launches narcolepsy drug targeting root cause

· Health · Japan

Japan's Takeda debuted a narcolepsy drug that targets the root cause of the condition, capping a 15-year development effort. The drug represents a shift from symptom management toward addressing underlying mechanisms.

Why it matters：A root-cause treatment could change care for narcolepsy patients and signals Japan's push into specialized neuroscience drugs.

Key points

  • Takeda's narcolepsy drug targets the root cause.
  • It culminated a 15-year development effort.

Sources (original reporting)

More stories from this day